Recently, USANA Health Sciences announced preliminary third-quarter results that missed expectations, with the company anticipating a net loss of US$6.5 million compared to a profit a year earlier.
USANA faces short-term challenges from profitability declines and business shifts despite solid sales and no debt. Find out ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback